Quick Answer
International Stem Cell CORP reported Total Assets of $4.82 million for fiscal year 2025.
International Stem Cell CORP Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $4.82M | -6.8% |
| 2024 | $5.17M | -4.0% |
| 2023 | $5.39M | +5.0% |
| 2022 | $5.13M | +3.8% |
| 2021 | $4.95M | -6.4% |
| 2020 | $5.29M | -20.1% |
| 2019 | $6.62M | -15.1% |
| 2018 | $7.80M | +13.6% |
| 2017 | $6.86M | -2.6% |
| 2016 | $7.04M | -1.3% |
| 2015 | $7.14M | -0.6% |
| 2014 | $7.18M | -7.2% |
| 2013 | $7.74M | +44.1% |
| 2012 | $5.37M | -6.4% |
| 2011 | $5.74M | -42.2% |
| 2010 | $9.93M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.28M | +2.0% | -4.8% |
| June 30, 2025 | $5.55M | -0.8% | -1.4% |
| March 31, 2025 | $5.62M | +4.7% | +8.7% |
| December 31, 2024 | $5.17M | -4.0% | -0.1% |
| September 30, 2024 | $5.18M | -8.2% | -7.4% |
| June 30, 2024 | $5.59M | -3.3% | +4.2% |
| March 31, 2024 | $5.37M | +0.5% | -0.4% |
| December 31, 2023 | $5.39M | +5.0% | -4.4% |
- International Stem Cell CORP showed a decrease of -6.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, International Stem Cell CORP’s total assets has declined by 51.5% (from $9.93 million to $4.82 million).
- The most recent figure is from International Stem Cell CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: